Gilead Sciences
GILD
$64.70
Share price
1.33%
Change (1 day)
-14.96%
Change (1 year)
Categories
Gilead Sciences (GILD) - Total debt
Total debt on the balance sheet as of March 2024 : $25.19 B
According to Gilead Sciences's latest financial reports the company's total debt is $25.19 B. A company’s total debt is the sum of all current and non-current debts.
Gilead Sciences - Total debt on balance sheet (from 2001 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $24.98 B | -0.96% |
| 2022-12-31 | $25.23 B | -5.49% |
| 2021-12-31 | $26.69 B | -14.99% |
| 2020-12-31 | $31.40 B | 27.69% |
| 2019-12-31 | $24.59 B | -9.99% |
| 2018-12-31 | $27.32 B | -18.54% |
| 2017-12-31 | $33.54 B | 27.31% |
| 2016-12-31 | $26.34 B | 19.46% |
| 2015-12-31 | $22.05 B | 77.81% |
| 2014-12-31 | $12.40 B | 86.92% |
| 2013-12-31 | $6.63 B | -19.31% |
| 2012-12-31 | $8.22 B | 8.11% |
| 2011-12-31 | $7.60 B | 118.29% |
| 2010-12-31 | $3.48 B | 179.15% |
| 2009-12-31 | $1.24 B | 7.6% |
| 2008-12-31 | $1.16 B | -11.56% |
| 2007-12-31 | $1.31 B | -7% |
| 2006-12-31 | $1.41 B | 368.86% |
| 2005-12-31 | $0.30 B | 72395.42% |
| 2004-12-31 | $0.41 M | -99.88% |
| 2003-12-31 | $0.34 B | -41.98% |
| 2002-12-31 | $0.59 B | 136.41% |
| 2001-12-31 | $0.25 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $33.63 B | 33.49% | 🇺🇸 USA |
 Pfizer PFE | $68.70 B | 172.72% | 🇺🇸 USA |
 AbbVie ABBV | $74.00 B | 193.72% | 🇺🇸 USA |
 Eli Lilly LLY | $26.21 B | 4.04% | 🇺🇸 USA |
 Amgen AMGN | $64.02 B | 154.11% | 🇺🇸 USA |
 Biogen BIIB | $6.94 B | -72.43% | 🇺🇸 USA |
 Illumina ILMN | $2.27 B | -90.97% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $0.72 B | -97.14% | 🇺🇸 USA |
 Merck MRK | $34.21 B | 35.82% | 🇺🇸 USA |